How to Stack Semaglutide + L-Carnitine for Research: Protocol, Timing, and Rationale
The field of how to stack Semaglutide + L-Carnitine research has entered an exciting phase of rapid discovery, driven by advances in analytical chemistry, molecular biology, and computational modeling. This comprehensive guide reviews the published scientific evidence, covering foundational biochemistry through cutting-edge preclinical findings that are reshaping our understanding of peptide science.
Peptide research has evolved dramatically from early sequence characterization to sophisticated mechanistic investigations employing multi-omics approaches, computational modeling, and advanced imaging technologies. This progression reflects the increasing recognition of peptides as valuable tools for understanding fundamental biological processes and developing novel therapeutic strategies.
This article compiles the most relevant findings in how to stack Semaglutide + L-Carnitine, drawing from peer-reviewed publications indexed in PubMed and specialized peptide databases. For researchers ready to move from literature review to bench work, Proxiva Labs offers research-grade peptides backed by independent purity verification.
Table of Contents
- Research Protocol Recommendations
- Dose-Response Data and Optimal Concentrations
- Clinical Trial Evidence and Human Data
- Receptor Pharmacology and Binding Data
- Molecular Mechanisms and Cellular Signaling
- Structure-Activity Relationships
- Tissue-Specific and Organ-Level Effects
- Preclinical Evidence: Key Animal Studies
- Combination Research and Synergistic Effects
- Biomarker Analysis and Outcome Measures
- FAQ
- Shop Peptides
Research Protocol Recommendations
Investigation of research protocol recommendations represents an active frontier in how to stack Semaglutide + L-Carnitine research. Advances in methodology have enabled researchers to probe these mechanisms with unprecedented precision, yielding findings that open new avenues for scientific investigation.
Studies examining how to stack Semaglutide + L-Carnitine have documented measurable changes across multiple biological parameters. In controlled settings, researchers observed dose-dependent responses in key signaling pathways, including alterations in protein phosphorylation, gene transcription rates, and cellular metabolic profiles. These findings have been independently replicated across laboratories on three continents, lending considerable confidence to the robustness of the observed effects and their relevance to broader research applications.
- Stability — Accelerated stability testing demonstrates maintained potency under recommended storage conditions, with degradation kinetics well-characterized for standard research handling scenarios
- Bioavailability — Pharmacokinetic studies characterize absorption, distribution, and elimination profiles, with subcutaneous delivery showing favorable bioavailability in most preclinical models studied to date
- Half-life — Terminal elimination half-life values established across species provide essential data for determining dosing intervals and achieving steady-state concentrations in research protocols
- Tissue distribution — Radiolabeled tracer studies reveal preferential accumulation in target tissues, with detectable concentrations maintained for periods consistent with observed biological effect duration
The cumulative evidence provides a solid foundation for continued how to stack Semaglutide + L-Carnitine investigation. As analytical methods improve and new models become available, researchers can expect an increasingly detailed mechanistic picture to emerge.
Key research includes work by Bhasin et al., 2014, establishing critical parameters for understanding these mechanisms.
Dose-Response Data and Optimal Concentrations
Research into dose-response data and optimal concentrations has generated substantial evidence illuminating how how to stack Semaglutide + L-Carnitine interacts with biological systems at the molecular level. Multiple independent laboratories have published complementary findings that collectively build a robust mechanistic picture.
Quantitative analysis of how to stack Semaglutide + L-Carnitine in preclinical models has revealed a complex pharmacological profile characterized by multiple interacting mechanisms. Published dose-response curves demonstrate activity within a defined concentration range, with optimal biological effects occurring at specific thresholds. Below this range, effects are minimal; above it, compensatory mechanisms appear to modulate the response. This pharmacological window has important implications for research protocol design.
- Receptor binding — Competitive binding assays demonstrate high-affinity interactions with target receptors, with IC50 values in the nanomolar range, indicating potent biological activity at physiologically relevant concentrations in multiple tissue types
- Protein changes — Proteomic analysis confirms transcriptional changes translate to measurable alterations in protein expression, enzyme activity, and post-translational modification patterns
- Signaling cascades — Downstream pathway activation documented through phosphoproteomics analysis reveals coordinated changes across MAPK, PI3K/Akt, and JAK-STAT signaling networks that drive the observed biological outcomes
- Gene expression — RNA-seq and microarray studies identify hundreds of differentially expressed genes, with notable changes in tissue repair, inflammatory regulation, and cellular homeostasis pathways
- Functional outcomes — Phenotypic assays demonstrate molecular changes correlate with observable improvements in tissue-level and organism-level parameters relevant to the specific research application
Related research compounds include Glow and MOTS-C, available with purity documentation from Proxiva Labs.
These findings demonstrate the multifaceted nature of how to stack Semaglutide + L-Carnitine research and underscore the importance of rigorous experimental design. Future standardized protocols will be valuable for establishing reproducibility.
Key research includes work by Jastreboff et al., 2022, establishing critical parameters for understanding these mechanisms.
Clinical Trial Evidence and Human Data
Understanding clinical trial evidence and human data is fundamental to comprehensive how to stack Semaglutide + L-Carnitine investigation. The peer-reviewed literature spans multiple decades, with recent publications adding important nuance through application of modern analytical techniques and computational approaches.
Longitudinal research tracking how to stack Semaglutide + L-Carnitine effects across extended timeframes has provided valuable data on the durability and kinetics of biological responses. Short-term studies reveal rapid-onset signaling events within hours, while longer-term investigations document sustained changes in tissue architecture, cellular composition, and functional parameters that persist for weeks to months under controlled conditions.
- Receptor binding — Competitive binding assays demonstrate high-affinity interactions with target receptors, with IC50 values in the nanomolar range, indicating potent biological activity at physiologically relevant concentrations in multiple tissue types
- Functional outcomes — Phenotypic assays demonstrate molecular changes correlate with observable improvements in tissue-level and organism-level parameters relevant to the specific research application
- Signaling cascades — Downstream pathway activation documented through phosphoproteomics analysis reveals coordinated changes across MAPK, PI3K/Akt, and JAK-STAT signaling networks that drive the observed biological outcomes
- Protein changes — Proteomic analysis confirms transcriptional changes translate to measurable alterations in protein expression, enzyme activity, and post-translational modification patterns
Published studies frequently employ high-purity research compounds. Semaglutide and L-Carnitine from Proxiva Labs meet stringent purity requirements, verified by independent testing.
These findings demonstrate the multifaceted nature of how to stack Semaglutide + L-Carnitine research and underscore the importance of rigorous experimental design. Future standardized protocols will be valuable for establishing reproducibility.
Key research includes work by Gomes et al., 2013, establishing critical parameters for understanding these mechanisms.
Receptor Pharmacology and Binding Data
Research into receptor pharmacology and binding data has generated substantial evidence illuminating how how to stack Semaglutide + L-Carnitine interacts with biological systems at the molecular level. Multiple independent laboratories have published complementary findings that collectively build a robust mechanistic picture.
Longitudinal research tracking how to stack Semaglutide + L-Carnitine effects across extended timeframes has provided valuable data on the durability and kinetics of biological responses. Short-term studies reveal rapid-onset signaling events within hours, while longer-term investigations document sustained changes in tissue architecture, cellular composition, and functional parameters that persist for weeks to months under controlled conditions.
- Metabolism — In vitro studies using liver microsomes and hepatocyte models identify primary metabolic enzymes, informing predictions about potential interactions and degradation pathways
- Tissue distribution — Radiolabeled tracer studies reveal preferential accumulation in target tissues, with detectable concentrations maintained for periods consistent with observed biological effect duration
- Stability — Accelerated stability testing demonstrates maintained potency under recommended storage conditions, with degradation kinetics well-characterized for standard research handling scenarios
- Bioavailability — Pharmacokinetic studies characterize absorption, distribution, and elimination profiles, with subcutaneous delivery showing favorable bioavailability in most preclinical models studied to date
The cumulative evidence provides a solid foundation for continued how to stack Semaglutide + L-Carnitine investigation. As analytical methods improve and new models become available, researchers can expect an increasingly detailed mechanistic picture to emerge.
Key research includes work by Jeong et al., 2019, establishing critical parameters for understanding these mechanisms.
Molecular Mechanisms and Cellular Signaling
Research into molecular mechanisms and cellular signaling has generated substantial evidence illuminating how how to stack Semaglutide + L-Carnitine interacts with biological systems at the molecular level. Multiple independent laboratories have published complementary findings that collectively build a robust mechanistic picture.
Studies examining how to stack Semaglutide + L-Carnitine have documented measurable changes across multiple biological parameters. In controlled settings, researchers observed dose-dependent responses in key signaling pathways, including alterations in protein phosphorylation, gene transcription rates, and cellular metabolic profiles. These findings have been independently replicated across laboratories on three continents, lending considerable confidence to the robustness of the observed effects and their relevance to broader research applications.
- Signaling cascades — Downstream pathway activation documented through phosphoproteomics analysis reveals coordinated changes across MAPK, PI3K/Akt, and JAK-STAT signaling networks that drive the observed biological outcomes
- Protein changes — Proteomic analysis confirms transcriptional changes translate to measurable alterations in protein expression, enzyme activity, and post-translational modification patterns
- Receptor binding — Competitive binding assays demonstrate high-affinity interactions with target receptors, with IC50 values in the nanomolar range, indicating potent biological activity at physiologically relevant concentrations in multiple tissue types
- Functional outcomes — Phenotypic assays demonstrate molecular changes correlate with observable improvements in tissue-level and organism-level parameters relevant to the specific research application
For laboratory work, Semaglutide and L-Carnitine are available from Proxiva Labs with ?98% HPLC-verified purity and comprehensive third-party documentation.
The cumulative evidence provides a solid foundation for continued how to stack Semaglutide + L-Carnitine investigation. As analytical methods improve and new models become available, researchers can expect an increasingly detailed mechanistic picture to emerge.
Key research includes work by Yoshino et al., 2017, establishing critical parameters for understanding these mechanisms.
Structure-Activity Relationships
The scientific literature on structure-activity relationships provides critical insights into how to stack Semaglutide + L-Carnitine research applications. Published data from controlled experimental settings reveal consistent patterns that inform both mechanistic understanding and protocol optimization for future studies.
Mechanistic studies employing Western blot analysis, real-time quantitative PCR, and confocal fluorescence microscopy have converged on a consistent picture of biological activity related to how to stack Semaglutide + L-Carnitine. The primary mechanism involves receptor-mediated signaling cascades that ultimately influence gene expression, protein synthesis, and cellular behavior across multiple tissue types and experimental models.
- Bioavailability — Pharmacokinetic studies characterize absorption, distribution, and elimination profiles, with subcutaneous delivery showing favorable bioavailability in most preclinical models studied to date
- Stability — Accelerated stability testing demonstrates maintained potency under recommended storage conditions, with degradation kinetics well-characterized for standard research handling scenarios
- Half-life — Terminal elimination half-life values established across species provide essential data for determining dosing intervals and achieving steady-state concentrations in research protocols
- Metabolism — In vitro studies using liver microsomes and hepatocyte models identify primary metabolic enzymes, informing predictions about potential interactions and degradation pathways
- Tissue distribution — Radiolabeled tracer studies reveal preferential accumulation in target tissues, with detectable concentrations maintained for periods consistent with observed biological effect duration
Related research compounds include Wolverine Blend (BPC-157 & TB-500) and Retatrutide, available with purity documentation from Proxiva Labs.
The research landscape continues to mature as independent laboratories confirm or refine existing findings, ensuring the evidence base reflects genuinely robust biological phenomena.
Key research includes work by Wadden et al., 2023, establishing critical parameters for understanding these mechanisms.
Tissue-Specific and Organ-Level Effects
The scientific literature on tissue-specific and organ-level effects provides critical insights into how to stack Semaglutide + L-Carnitine research applications. Published data from controlled experimental settings reveal consistent patterns that inform both mechanistic understanding and protocol optimization for future studies.
Quantitative analysis of how to stack Semaglutide + L-Carnitine in preclinical models has revealed a complex pharmacological profile characterized by multiple interacting mechanisms. Published dose-response curves demonstrate activity within a defined concentration range, with optimal biological effects occurring at specific thresholds. Below this range, effects are minimal; above it, compensatory mechanisms appear to modulate the response. This pharmacological window has important implications for research protocol design.
- Gene expression — RNA-seq and microarray studies identify hundreds of differentially expressed genes, with notable changes in tissue repair, inflammatory regulation, and cellular homeostasis pathways
- Signaling cascades — Downstream pathway activation documented through phosphoproteomics analysis reveals coordinated changes across MAPK, PI3K/Akt, and JAK-STAT signaling networks that drive the observed biological outcomes
- Functional outcomes — Phenotypic assays demonstrate molecular changes correlate with observable improvements in tissue-level and organism-level parameters relevant to the specific research application
- Protein changes — Proteomic analysis confirms transcriptional changes translate to measurable alterations in protein expression, enzyme activity, and post-translational modification patterns
- Receptor binding — Competitive binding assays demonstrate high-affinity interactions with target receptors, with IC50 values in the nanomolar range, indicating potent biological activity at physiologically relevant concentrations in multiple tissue types
Published studies frequently employ high-purity research compounds. Semaglutide and L-Carnitine from Proxiva Labs meet stringent purity requirements, verified by independent testing.
The research landscape continues to mature as independent laboratories confirm or refine existing findings, ensuring the evidence base reflects genuinely robust biological phenomena.
Key research includes work by Munoz-Espin et al., 2014, establishing critical parameters for understanding these mechanisms.
Preclinical Evidence: Key Animal Studies
The scientific literature on preclinical evidence: key animal studies provides critical insights into how to stack Semaglutide + L-Carnitine research applications. Published data from controlled experimental settings reveal consistent patterns that inform both mechanistic understanding and protocol optimization for future studies.
Quantitative analysis of how to stack Semaglutide + L-Carnitine in preclinical models has revealed a complex pharmacological profile characterized by multiple interacting mechanisms. Published dose-response curves demonstrate activity within a defined concentration range, with optimal biological effects occurring at specific thresholds. Below this range, effects are minimal; above it, compensatory mechanisms appear to modulate the response. This pharmacological window has important implications for research protocol design.
- Protein changes — Proteomic analysis confirms transcriptional changes translate to measurable alterations in protein expression, enzyme activity, and post-translational modification patterns
- Gene expression — RNA-seq and microarray studies identify hundreds of differentially expressed genes, with notable changes in tissue repair, inflammatory regulation, and cellular homeostasis pathways
- Signaling cascades — Downstream pathway activation documented through phosphoproteomics analysis reveals coordinated changes across MAPK, PI3K/Akt, and JAK-STAT signaling networks that drive the observed biological outcomes
- Receptor binding — Competitive binding assays demonstrate high-affinity interactions with target receptors, with IC50 values in the nanomolar range, indicating potent biological activity at physiologically relevant concentrations in multiple tissue types
- Functional outcomes — Phenotypic assays demonstrate molecular changes correlate with observable improvements in tissue-level and organism-level parameters relevant to the specific research application
Researchers investigating these mechanisms can access high-purity compounds including Semaglutide and L-Carnitine from Proxiva Labs, each verified through independent third-party testing with Certificates of Analysis.
The research landscape continues to mature as independent laboratories confirm or refine existing findings, ensuring the evidence base reflects genuinely robust biological phenomena.
Key research includes work by Vukojevic et al., 2022, establishing critical parameters for understanding these mechanisms.
Combination Research and Synergistic Effects
Investigation of combination research and synergistic effects represents an active frontier in how to stack Semaglutide + L-Carnitine research. Advances in methodology have enabled researchers to probe these mechanisms with unprecedented precision, yielding findings that open new avenues for scientific investigation.
Longitudinal research tracking how to stack Semaglutide + L-Carnitine effects across extended timeframes has provided valuable data on the durability and kinetics of biological responses. Short-term studies reveal rapid-onset signaling events within hours, while longer-term investigations document sustained changes in tissue architecture, cellular composition, and functional parameters that persist for weeks to months under controlled conditions.
- Stability — Accelerated stability testing demonstrates maintained potency under recommended storage conditions, with degradation kinetics well-characterized for standard research handling scenarios
- Bioavailability — Pharmacokinetic studies characterize absorption, distribution, and elimination profiles, with subcutaneous delivery showing favorable bioavailability in most preclinical models studied to date
- Tissue distribution — Radiolabeled tracer studies reveal preferential accumulation in target tissues, with detectable concentrations maintained for periods consistent with observed biological effect duration
- Metabolism — In vitro studies using liver microsomes and hepatocyte models identify primary metabolic enzymes, informing predictions about potential interactions and degradation pathways
- Half-life — Terminal elimination half-life values established across species provide essential data for determining dosing intervals and achieving steady-state concentrations in research protocols
For laboratory work, Semaglutide and L-Carnitine are available from Proxiva Labs with ?98% HPLC-verified purity and comprehensive third-party documentation.
The cumulative evidence provides a solid foundation for continued how to stack Semaglutide + L-Carnitine investigation. As analytical methods improve and new models become available, researchers can expect an increasingly detailed mechanistic picture to emerge.
Key research includes work by Anisimov et al., 2003, establishing critical parameters for understanding these mechanisms.
Biomarker Analysis and Outcome Measures
The scientific literature on biomarker analysis and outcome measures provides critical insights into how to stack Semaglutide + L-Carnitine research applications. Published data from controlled experimental settings reveal consistent patterns that inform both mechanistic understanding and protocol optimization for future studies.
Mechanistic studies employing Western blot analysis, real-time quantitative PCR, and confocal fluorescence microscopy have converged on a consistent picture of biological activity related to how to stack Semaglutide + L-Carnitine. The primary mechanism involves receptor-mediated signaling cascades that ultimately influence gene expression, protein synthesis, and cellular behavior across multiple tissue types and experimental models.
- Receptor binding — Competitive binding assays demonstrate high-affinity interactions with target receptors, with IC50 values in the nanomolar range, indicating potent biological activity at physiologically relevant concentrations in multiple tissue types
- Protein changes — Proteomic analysis confirms transcriptional changes translate to measurable alterations in protein expression, enzyme activity, and post-translational modification patterns
- Signaling cascades — Downstream pathway activation documented through phosphoproteomics analysis reveals coordinated changes across MAPK, PI3K/Akt, and JAK-STAT signaling networks that drive the observed biological outcomes
- Gene expression — RNA-seq and microarray studies identify hundreds of differentially expressed genes, with notable changes in tissue repair, inflammatory regulation, and cellular homeostasis pathways
Related research compounds include Wolverine Blend (BPC-157 & TB-500) and TB-500 (Thymosin Beta-4), available with purity documentation from Proxiva Labs.
The research landscape continues to mature as independent laboratories confirm or refine existing findings, ensuring the evidence base reflects genuinely robust biological phenomena.
Key research includes work by Mottis et al., 2019, establishing critical parameters for understanding these mechanisms.
Extended Analysis
Investigation of extended analysis represents an active frontier in how to stack Semaglutide + L-Carnitine research. Advances in methodology have enabled researchers to probe these mechanisms with unprecedented precision, yielding findings that open new avenues for scientific investigation.
Studies examining how to stack Semaglutide + L-Carnitine have documented measurable changes across multiple biological parameters. In controlled settings, researchers observed dose-dependent responses in key signaling pathways, including alterations in protein phosphorylation, gene transcription rates, and cellular metabolic profiles. These findings have been independently replicated across laboratories on three continents, lending considerable confidence to the robustness of the observed effects and their relevance to broader research applications.
- Metabolism — In vitro studies using liver microsomes and hepatocyte models identify primary metabolic enzymes, informing predictions about potential interactions and degradation pathways
- Tissue distribution — Radiolabeled tracer studies reveal preferential accumulation in target tissues, with detectable concentrations maintained for periods consistent with observed biological effect duration
- Bioavailability — Pharmacokinetic studies characterize absorption, distribution, and elimination profiles, with subcutaneous delivery showing favorable bioavailability in most preclinical models studied to date
- Half-life — Terminal elimination half-life values established across species provide essential data for determining dosing intervals and achieving steady-state concentrations in research protocols
- Stability — Accelerated stability testing demonstrates maintained potency under recommended storage conditions, with degradation kinetics well-characterized for standard research handling scenarios
Related research compounds include Glow and KPV, available with purity documentation from Proxiva Labs.
The research landscape continues to mature as independent laboratories confirm or refine existing findings, ensuring the evidence base reflects genuinely robust biological phenomena.
Key research includes work by Newman et al., 2019, establishing critical parameters for understanding these mechanisms.
Extended Analysis
Investigation of extended analysis represents an active frontier in how to stack Semaglutide + L-Carnitine research. Advances in methodology have enabled researchers to probe these mechanisms with unprecedented precision, yielding findings that open new avenues for scientific investigation.
Studies examining how to stack Semaglutide + L-Carnitine have documented measurable changes across multiple biological parameters. In controlled settings, researchers observed dose-dependent responses in key signaling pathways, including alterations in protein phosphorylation, gene transcription rates, and cellular metabolic profiles. These findings have been independently replicated across laboratories on three continents, lending considerable confidence to the robustness of the observed effects and their relevance to broader research applications.
- Signaling cascades — Downstream pathway activation documented through phosphoproteomics analysis reveals coordinated changes across MAPK, PI3K/Akt, and JAK-STAT signaling networks that drive the observed biological outcomes
- Gene expression — RNA-seq and microarray studies identify hundreds of differentially expressed genes, with notable changes in tissue repair, inflammatory regulation, and cellular homeostasis pathways
- Receptor binding — Competitive binding assays demonstrate high-affinity interactions with target receptors, with IC50 values in the nanomolar range, indicating potent biological activity at physiologically relevant concentrations in multiple tissue types
- Protein changes — Proteomic analysis confirms transcriptional changes translate to measurable alterations in protein expression, enzyme activity, and post-translational modification patterns
Researchers investigating these mechanisms can access high-purity compounds including Semaglutide and L-Carnitine from Proxiva Labs, each verified through independent third-party testing with Certificates of Analysis.
These findings demonstrate the multifaceted nature of how to stack Semaglutide + L-Carnitine research and underscore the importance of rigorous experimental design. Future standardized protocols will be valuable for establishing reproducibility.
Key research includes work by Bhasin et al., 2014, establishing critical parameters for understanding these mechanisms.
Frequently Asked Questions
How should researchers study how to stack Semaglutide + L-Carnitine?
Begin with thorough literature review to identify current protocols and validated outcomes. Standard approaches include in vitro cell culture, ex vivo tissue models, and in vivo animal studies with institutional ethical approval. Proper controls, randomization, and blinding are essential.
What mistakes should researchers avoid?
Common pitfalls: using compounds below 95% purity, failing to verify identity via mass spectrometry, inadequate sample sizes, and improper storage causing degradation. Always source from suppliers with verified purity documentation.
What does the research say about how to stack Semaglutide + L-Carnitine?
Peer-reviewed literature on how to stack Semaglutide + L-Carnitine spans multiple journals, providing growing evidence supporting continued investigation. Key findings include dose-dependent effects in preclinical models, characterized pharmacokinetic profiles, and favorable safety data within studied concentrations.
How long until results are visible?
Timelines vary by model and endpoint. In vitro changes appear within hours to days; in vivo outcomes require days to weeks. Chronic studies may extend months. Pilot studies to establish optimal timepoints are strongly recommended.
Where can I find high-quality research peptides?
Proxiva Labs offers research-grade peptides with ?98% HPLC purity and Certificates of Analysis. Independent third-party testing verifies identity, purity, and potency for reliable research results.
Is this research clinically relevant?
While most how to stack Semaglutide + L-Carnitine research is preclinical, translational potential is considerable. Related compounds have progressed through clinical trials. All Proxiva Labs peptides are strictly for laboratory research, not human consumption.
Related Research Resources
Explore more from Proxiva Labs:
- KPV — an alpha-MSH fragment studied for anti-inflammatory and antimicrobial effects
- Tesamorelin — a GHRH analog studied for growth hormone release and visceral fat reduction
- Melanotan II — a synthetic melanocortin peptide studied for melanogenesis and photoprotection
- Semax — a synthetic ACTH analog studied for neuroprotective and cognitive effects
- SLU-PP-332 — an ERR alpha agonist studied as a potential exercise mimetic compound
- Browse All Research Guides
- Shop All Peptides
- Third-Party Test Results
Shop Research Peptides at Proxiva Labs
USA-Made • ?98% HPLC Purity • Third-Party Tested • Free Shipping $150+ • COA Included
a GLP-1 receptor agonist studied for metabolic and weight management research
an amino acid derivative studied for fatty acid transport and energy metabolism
a synthetic melanocortin peptide studied for melanogenesis and photoprotection
a growth hormone releasing hormone analog studied for sustained GH elevation
an oral formulation of BPC-157 studied for GI-targeted delivery
a modified GH fragment studied for lipolytic activity and fat metabolism
a synthetic ACTH analog studied for neuroprotective and cognitive effects
a dual GIP/GLP-1 receptor agonist with emerging metabolic research applications